IGFBP3 Regulates Hypocretin (Orexin)
Author Information
Author(s): Honda Makoto, Eriksson Krister S., Zhang Shengwen, Tanaka Susumu, Lin Ling, Salehi Ahmad, Hesla Per Egil, Maehlen Jan, Gaus Stephanie E., Yanagisawa Masashi, Sakurai Takeshi, Taheri Shahrad, Tsuchiya Kuniaki, Honda Yutaka, Mignot Emmanuel
Primary Institution: Stanford University
Hypothesis
Excessive IGFBP3 expression may initiate hypocretin cell death and cause narcolepsy.
Conclusion
IGFBP3 is a new regulator of hypocretin cell physiology that may be involved in the pathophysiology of narcolepsy and sleep regulation.
Supporting Evidence
- IGFBP3 was the only gene confirmed to be downregulated in both human and mouse models of narcolepsy.
- Functional analysis indicated decreased hypocretin levels in mice overexpressing IGFBP3.
- An IGFBP3 polymorphism was associated with lower CSF hypocretin-1 levels in normal individuals.
- Microarray analysis revealed significant downregulation of hypocretin in narcoleptic brains.
Takeaway
This study found that a protein called IGFBP3 affects sleep by regulating another protein called hypocretin, which is important for staying awake.
Methodology
Microarrays were used to compare gene expression in the hypothalamus of narcoleptic versus control brains and in transgenic mice lacking hypocretin neurons.
Potential Biases
Potential bias in sample selection and the interpretation of postmortem brain data.
Limitations
The study primarily focused on a limited number of genes and may not account for all factors influencing narcolepsy.
Participant Demographics
The study included 9 narcoleptic patients and 14 control subjects, primarily Caucasian.
Statistical Information
P-Value
0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website